KR100402636B1 - 17-스피로메틸렌락톤또는락톨기를갖는스테로이드 - Google Patents

17-스피로메틸렌락톤또는락톨기를갖는스테로이드 Download PDF

Info

Publication number
KR100402636B1
KR100402636B1 KR1019950038035A KR19950038035A KR100402636B1 KR 100402636 B1 KR100402636 B1 KR 100402636B1 KR 1019950038035 A KR1019950038035 A KR 1019950038035A KR 19950038035 A KR19950038035 A KR 19950038035A KR 100402636 B1 KR100402636 B1 KR 100402636B1
Authority
KR
South Korea
Prior art keywords
hydroxy
lactone
alkyl
norcola
diene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019950038035A
Other languages
English (en)
Korean (ko)
Other versions
KR960014152A (ko
Inventor
요하네스안토니우스마리아하메르스마
얍반데어라우프
Original Assignee
악조 노벨 엔.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 악조 노벨 엔.브이. filed Critical 악조 노벨 엔.브이.
Publication of KR960014152A publication Critical patent/KR960014152A/ko
Application granted granted Critical
Publication of KR100402636B1 publication Critical patent/KR100402636B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0092—Alkenyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019950038035A 1994-10-27 1995-10-26 17-스피로메틸렌락톤또는락톨기를갖는스테로이드 Expired - Fee Related KR100402636B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94203117 1994-10-27
EP94-203117.0 1994-10-27

Publications (2)

Publication Number Publication Date
KR960014152A KR960014152A (ko) 1996-05-22
KR100402636B1 true KR100402636B1 (ko) 2004-02-05

Family

ID=8217314

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950038035A Expired - Fee Related KR100402636B1 (ko) 1994-10-27 1995-10-26 17-스피로메틸렌락톤또는락톨기를갖는스테로이드

Country Status (26)

Country Link
US (1) US5741786A (https=)
EP (1) EP0709394B1 (https=)
JP (1) JPH08225590A (https=)
KR (1) KR100402636B1 (https=)
CN (1) CN1052237C (https=)
AT (1) ATE199015T1 (https=)
AU (1) AU689642B2 (https=)
BR (1) BR9504576A (https=)
CA (1) CA2161490A1 (https=)
CZ (1) CZ287346B6 (https=)
DE (1) DE69520022T2 (https=)
DK (1) DK0709394T3 (https=)
ES (1) ES2157290T3 (https=)
FI (1) FI113542B (https=)
GR (1) GR3035713T3 (https=)
HU (1) HU221192B1 (https=)
IL (1) IL115659A (https=)
NO (1) NO305252B1 (https=)
NZ (1) NZ280325A (https=)
PL (1) PL187083B1 (https=)
PT (1) PT709394E (https=)
RU (1) RU2168516C2 (https=)
SG (1) SG33569A1 (https=)
TR (1) TR199501327A2 (https=)
TW (1) TW339337B (https=)
ZA (1) ZA958963B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
DE19651000A1 (de) * 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US6043235A (en) * 1999-07-21 2000-03-28 Research Triangle Institute 11β-aryl-17, 17-spirothiolane-substituted steroids
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
EP1945240B1 (en) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
WO2021198467A1 (en) * 2020-04-03 2021-10-07 Rockwool International A/S Method of draining water

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2875199A (en) * 1958-04-22 1959-02-24 Searle & Co Lactones of 17-carboxyalkylated estra-1, 3, 5(10)-triene-3, 17-diols and 3-ethers
US3547912A (en) * 1968-07-29 1970-12-15 American Home Prod Derivatives of 2h-pyran-3(6h)-ones and preparation thereof
US3764596A (en) * 1971-06-22 1973-10-09 Sandoz Ag 17-dihydrofuranyl-substituted steroids
DE3306554A1 (de) * 1983-02-22 1984-08-23 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von 3-((delta)(pfeil hoch)4(pfeil hoch)-3-ketosteroid-17(alpha)-yl)-propionsaeurelactonen
DE3347510A1 (de) * 1983-12-27 1985-08-01 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von 3-oxo-17(alpha)-pregna-4,6-dien-21,17-carbolactonen
FR2596395B1 (fr) * 1986-03-26 1989-05-26 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
ES2053714T3 (es) * 1987-12-12 1994-08-01 Akzo Nv Proceso para la preparacion de 11-arilesteroides.
FR2688004A1 (fr) * 1992-02-27 1993-09-03 Roussel Uclaf Nouveaux sterouides comportant en position 17 un radical methylene lactone, leur procede et des intermediaires de preparation, leur application comme medicaments.

Also Published As

Publication number Publication date
PT709394E (pt) 2001-06-29
CA2161490A1 (en) 1996-04-28
NO305252B1 (no) 1999-04-26
ATE199015T1 (de) 2001-02-15
GR3035713T3 (en) 2001-07-31
EP0709394B1 (en) 2001-01-31
IL115659A (en) 2000-06-01
HU221192B1 (en) 2002-08-28
DE69520022D1 (de) 2001-03-08
PL187083B1 (pl) 2004-05-31
RU2168516C2 (ru) 2001-06-10
KR960014152A (ko) 1996-05-22
FI955108L (fi) 1996-04-28
SG33569A1 (en) 1996-10-18
EP0709394A2 (en) 1996-05-01
ZA958963B (en) 1996-05-23
NO954293D0 (no) 1995-10-26
IL115659A0 (en) 1996-01-19
PL311135A1 (en) 1996-04-29
DE69520022T2 (de) 2001-06-13
NZ280325A (en) 1997-03-24
EP0709394A3 (en) 1996-09-18
AU3445795A (en) 1996-05-09
TR199501327A3 (https=) 1996-06-21
AU689642B2 (en) 1998-04-02
BR9504576A (pt) 1997-05-20
US5741786A (en) 1998-04-21
CN1131158A (zh) 1996-09-18
TR199501327A2 (tr) 1996-06-21
FI955108A0 (fi) 1995-10-26
HU9503068D0 (en) 1995-12-28
HUT73482A (en) 1996-08-28
CZ275595A3 (en) 1996-05-15
JPH08225590A (ja) 1996-09-03
FI113542B (fi) 2004-05-14
DK0709394T3 (da) 2001-06-18
ES2157290T3 (es) 2001-08-16
CZ287346B6 (en) 2000-10-11
CN1052237C (zh) 2000-05-10
TW339337B (en) 1998-09-01
NO954293L (no) 1996-04-29

Similar Documents

Publication Publication Date Title
EP0582338B1 (en) 17-Spiromethylene steroids
CA2084431C (en) 17-spirofuran-3'-ylidene steroids
CA1326015C (en) 19,11.beta.-bridged steroids, their manufacture and pharmaceutical preparations containing them
JP2664390B2 (ja) 新規な１１−アリールステロイド誘導体
KR100402636B1 (ko) 17-스피로메틸렌락톤또는락톨기를갖는스테로이드
JP2655676B2 (ja) 新規な１１−アリールエストラン及び１１−アリールプレグナン誘導体
JP2003515543A (ja) １４，１５−ベータ−メチレン置換されたアンドロゲン
KR100341066B1 (ko) 게스타겐활성의19,11-다리결합4-에스트렌
US5446178A (en) Process for preparing 19,11β-bridged steroids
KR100400621B1 (ko) 14알파,17알파-c2-브리지된19-노르-프로게스테론유도체
KR100730010B1 (ko) 신규 안드로겐
HK1002033B (en) 17-spirofuran-3'-ylidene steroids

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20061010

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20061010